Phase 0/I/II Cancer Prevention Clinical Trials Program Clinical Trials

Title Intervention NCT IDsort descending Sponsor Status
Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer genistein, laboratory biomarker analysis, placebo, therapeutic conventional surgery, pharmacological study NCT00118040 National Cancer Institute (NCI) Completed
Defined Green Tea Catechin Extract in Preventing Esophageal Cancer in Patients With Barrett's... placebo, defined green tea catechin extract NCT00233935 National Cancer Institute (NCI) Completed
Sulindac in Preventing Breast Cancer in Women at High Risk for Breast Cancer sulindac, laboratory biomarker analysis NCT00245024 National Cancer Institute (NCI) Completed
Genistein in Preventing Breast Cancer in Women at High Risk for Breast Cancer placebo, genistein, laboratory biomarker analysis NCT00290758 National Cancer Institute (NCI) Completed
Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade... placebo, defined green tea catechin extract, laboratory biomarker analysis NCT00303823 National Cancer Institute (NCI) Completed
Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung Cancer Budesonide, Placebo NCT00321893 National Cancer Institute (NCI) Completed
Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients... oligofructose-enriched inulin, sulindac, placebo, atorvastatin calcium, laboratory biomarker analysis NCT00335504 National Cancer Institute (NCI) Completed
Sulindac Capsules Compared With Sulindac Tablets in Healthy Volunteers sulindac, pharmacological study NCT00343629 Mayo Clinic Completed
Phase II A Trial of Curcumin Among Patients With Prevalent Subclinical Neoplastic Lesions (Aberrant... laboratory biomarker analysis, pharmacological study, curcumin NCT00365209 National Cancer Institute (NCI) Completed
Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia sulindac, placebo NCT00368927 National Cancer Institute (NCI) Completed

Pages